These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
254 related articles for article (PubMed ID: 22873799)
21. Ion- and pH-activated novel in-situ gel system for sustained ocular drug delivery. Gupta H; Velpandian T; Jain S J Drug Target; 2010 Aug; 18(7):499-505. PubMed ID: 20055752 [TBL] [Abstract][Full Text] [Related]
22. Poloxamer-based thermoresponsive ketorolac tromethamine in situ gel preparations: Design, characterisation, toxicity and transcorneal permeation studies. M A Fathalla Z; Vangala A; Longman M; Khaled KA; Hussein AK; El-Garhy OH; Alany RG Eur J Pharm Biopharm; 2017 May; 114():119-134. PubMed ID: 28126392 [TBL] [Abstract][Full Text] [Related]
23. Designing of a pH-Triggered Carbopol®/HPMC In Situ Gel for Ocular Delivery of Dorzolamide HCl: In Vitro, In Vivo, and Ex Vivo Evaluation. Kouchak M; Mahmoodzadeh M; Farrahi F AAPS PharmSciTech; 2019 Jun; 20(5):210. PubMed ID: 31161269 [TBL] [Abstract][Full Text] [Related]
24. Development and evaluation of novel surfactant-based elastic vesicular system for ocular delivery of fluconazole. Kaur IP; Rana C; Singh M; Bhushan S; Singh H; Kakkar S J Ocul Pharmacol Ther; 2012 Oct; 28(5):484-96. PubMed ID: 22694593 [TBL] [Abstract][Full Text] [Related]
25. In vitro and in vivo consideration of novel environmentally responsive ophthalmic drug delivery system. Deshmukh PK; Gattani SG Pharm Dev Technol; 2013; 18(4):950-6. PubMed ID: 22200332 [TBL] [Abstract][Full Text] [Related]
26. Microemulsion based vaginal gel of fluconazole: formulation, in vitro and in vivo evaluation. Bachhav YG; Patravale VB Int J Pharm; 2009 Jan; 365(1-2):175-9. PubMed ID: 18790032 [TBL] [Abstract][Full Text] [Related]
27. [Preparation and in vitro corneal retention behavior of novel cationic microemulsion/in situ gel system]. Ma SW; Gan Y; Gan L; Zhu CL; Zhu JB Yao Xue Xue Bao; 2008 Jul; 43(7):749-55. PubMed ID: 18819481 [TBL] [Abstract][Full Text] [Related]
28. Optimization of a novel in situ gel for sustained ocular drug delivery using Box-Behnken design: In vitro, ex vivo, in vivo and human studies. Ranch KM; Maulvi FA; Naik MJ; Koli AR; Parikh RK; Shah DO Int J Pharm; 2019 Jan; 554():264-275. PubMed ID: 30423418 [TBL] [Abstract][Full Text] [Related]
29. Development of antifungal fibrous ocular insert using freeze-drying technique. Teba HE; Khalil IA; Gebreel RM; Fahmy LI; Sorogy HME Drug Deliv Transl Res; 2024 Sep; 14(9):2520-2538. PubMed ID: 38366116 [TBL] [Abstract][Full Text] [Related]
30. Investigating The Retention Potential of Chitosan Nanoparticulate Gel: Design, Development, Kaul S; Jain N; Pandey J; Nagaich U Recent Pat Antiinfect Drug Discov; 2020; 15(1):41-67. PubMed ID: 31612834 [TBL] [Abstract][Full Text] [Related]
31. Acyclovir-Loaded Nanoemulsions: Preparation, Characterization and Irritancy Studies for Ophthalmic Delivery. Mohammadi M; Elahimehr Z; Mahboobian MM Curr Eye Res; 2021 Nov; 46(11):1646-1652. PubMed ID: 33979552 [No Abstract] [Full Text] [Related]
32. Fabrication of a composite system combining solid lipid nanoparticles and thermosensitive hydrogel for challenging ophthalmic drug delivery. Hao J; Wang X; Bi Y; Teng Y; Wang J; Li F; Li Q; Zhang J; Guo F; Liu J Colloids Surf B Biointerfaces; 2014 Feb; 114():111-20. PubMed ID: 24176890 [TBL] [Abstract][Full Text] [Related]
33. Fluconazole loaded chitin nanogels as a topical ocular drug delivery agent for corneal fungal infections. Mohammed N; Rejinold NS; Mangalathillam S; Biswas R; Nair SV; Jayakumar R J Biomed Nanotechnol; 2013 Sep; 9(9):1521-31. PubMed ID: 23980500 [TBL] [Abstract][Full Text] [Related]
34. Ocular supersaturated self-nanoemulsifying drug delivery systems (S-SNEDDS) to enhance econazole nitrate bioavailability. Elkasabgy NA Int J Pharm; 2014 Jan; 460(1-2):33-44. PubMed ID: 24184217 [TBL] [Abstract][Full Text] [Related]
35. Formulation and development of ophthalmic in situ gel for the treatment ocular inflammation and infection using application of quality by design concept. Patel N; Thakkar V; Metalia V; Baldaniya L; Gandhi T; Gohel M Drug Dev Ind Pharm; 2016 Sep; 42(9):1406-23. PubMed ID: 26716613 [TBL] [Abstract][Full Text] [Related]
36. In vitro and in vivo studies on ocular vitamin A palmitate cationic liposomal in situ gels. He W; Guo X; Feng M; Mao N Int J Pharm; 2013 Dec; 458(2):305-14. PubMed ID: 24409520 [TBL] [Abstract][Full Text] [Related]
37. Nanocubosomal based Hosny KM; Rizg WY; Alkhalidi HM; Abualsunun WA; Bakhaidar RB; Almehmady AM; Alghaith AF; Alshehri S; El Sisi AM Drug Deliv; 2021 Dec; 28(1):1836-1848. PubMed ID: 34515597 [TBL] [Abstract][Full Text] [Related]
38. Evaluation of gatifloxacin pluronic micelles and development of its formulation for ocular delivery. Kanoujia J; Kushwaha PS; Saraf SA Drug Deliv Transl Res; 2014 Aug; 4(4):334-43. PubMed ID: 25787066 [TBL] [Abstract][Full Text] [Related]
39. Thermoresponsive fluconazole gels for topical delivery: rheological and mechanical properties, in vitro drug release and anti-fungal efficacy. Gandra SC; Nguyen S; Nazzal S; Alayoubi A; Jung R; Nesamony J Pharm Dev Technol; 2015 Jan; 20(1):41-9. PubMed ID: 24160864 [TBL] [Abstract][Full Text] [Related]
40. Formulation and ex vivo-in vivo evaluation of pH-triggered brimonidine tartrate in situ gel for the glaucoma treatment using application of 3 Barse RK; Tagalpallewar AA; Kokare CR; Sharma JP; Sharma PK Drug Dev Ind Pharm; 2018 May; 44(5):800-807. PubMed ID: 29228819 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]